BJDX Bluejay Diagnostics Inc
Price (delayed)
$1.7
Market cap
$941,820
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$114.19
Enterprise value
-$3.14M
Highlights
BJDX's EPS has soared by 97% YoY and by 92% QoQ
Bluejay Diagnostics's debt has decreased by 37% YoY and by 8% from the previous quarter
BJDX's equity has surged by 98% year-on-year but it is down by 20% since the previous quarter
BJDX's quick ratio is down by 3.3% from the previous quarter
Key stats
What are the main financial stats of BJDX
Market
Valuations
Earnings
Shares outstanding
554,012
Market cap
$941,820
Enterprise value
-$3.14M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.16
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$7.17M
Net income
-$7.72M
EBIT
-$6.89M
EBITDA
-$6.7M
Free cash flow
-$8.13M
Per share
Balance sheet
Liquidity
EPS
-$114.19
EPS diluted
-$114.19
Free cash flow per share
-$44.31
Book value per share
$10.66
Revenue per share
$0
TBVPS
$36.3
Total assets
$6.66M
Total liabilities
$927,924
Debt
$222,249
Equity
$5.73M
Working capital
$4.09M
Debt to equity
0.04
Current ratio
6.05
Quick ratio
5.31
Net debt/EBITDA
0.61
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-270.7%
Return on equity
-336.4%
Return on invested capital
-464.9%
Return on capital employed
-117.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BJDX stock price
How has the Bluejay Diagnostics stock price performed over time
Intraday
1.8%
1 week
-0.58%
1 month
-55.38%
1 year
-99.34%
YTD
-65.09%
QTD
-54.42%
Financial performance
How have Bluejay Diagnostics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.17M
Net income
-$7.72M
Gross margin
N/A
Net margin
N/A
BJDX's operating income is up by 30% year-on-year and by 11% since the previous quarter
BJDX's net income is up by 22% year-on-year and by 10% since the previous quarter
Growth
What is Bluejay Diagnostics's growth rate over time
Valuation
What is Bluejay Diagnostics stock price valuation
P/E
N/A
P/B
0.16
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
BJDX's EPS has soared by 97% YoY and by 92% QoQ
BJDX's equity has surged by 98% year-on-year but it is down by 20% since the previous quarter
BJDX's P/B is 47% below its last 4 quarters average of 0.3
Efficiency
How efficient is Bluejay Diagnostics business performance
The ROA has plunged by 130% from the previous quarter and by 121% YoY
Bluejay Diagnostics's return on equity has shrunk by 116% QoQ and by 100% YoY
Bluejay Diagnostics's return on invested capital has increased by 19% QoQ and by 17% YoY
Dividends
What is BJDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BJDX.
Financial health
How did Bluejay Diagnostics financials performed over time
Bluejay Diagnostics's total liabilities has shrunk by 53% YoY and by 22% QoQ
The total assets rose by 37% YoY but it fell by 20% QoQ
Bluejay Diagnostics's debt is 96% less than its equity
BJDX's equity has surged by 98% year-on-year but it is down by 20% since the previous quarter
The company's debt to equity has shrunk by 67% YoY but it rose by 33% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.